InFlectis BioScience Overview
Founded
2013
Status
Private
Employees
10
Latest Deal Type
Series A
Latest Deal Amount
$6.8M
Investors
6
InFlectis BioScience General Information
Description
Developer of small molecule drugs intended to improve cellular defense system. The company's small molecule drugs identify preclinical-stage development products that modulate key proteins involved in misfolded protein disorders areas through early proof-of-concept, enabling clients to maximize the commercial value of each of its products, improve patient care and generate significant financial returns to its shareholders.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Biotechnology
Primary Office
- 21 rue La Noue Bras de Fer
- 44200 Nantes
- France
+33 02 00 00 00 00
InFlectis BioScience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 27-May-2016 | $6.8M | 00.000 | Completed | Generating Revenue | |
| 2. Seed Round | 13-Jan-2015 | 00.000 | 00.000 | Completed | Generating Revenue | |
| 1. Grant | 01-Jan-2014 | $411K | Completed | Generating Revenue |
InFlectis BioScience Competitors (39)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ContraFect | Formerly VC-backed | Yonkers, NY | 00 | 00000 | 000000000 | 00000 |
| 0000000 0000000000 | Venture Capital-Backed | New Haven, CT | 000.00 | 0000000000 0 | 000.00 | |
| 000000 00000000000 | Corporation | Cambridge, MA | 000 | 00000 | 000000 - 000 | 00000 |
| 000000000 00000000 | Venture Capital-Backed | Cambridge, MA | 00 | 000.00 | 0000000000 0 | 000.00 |
| 0000000 | Venture Capital-Backed | Framingham, MA | 0 | 0000 | 0000000000 0 | 0000 |
InFlectis BioScience Executive Team (4)
InFlectis BioScience Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Jérôme Guéret | GO Capital (France) | Board Member | 000 0000 |
| Philippe Guedat Ph.D | InFlectis BioScience | Co-Founder, Chief Executive Officer, Chairman, Managing Director & President | 000 0000 |
| Pierre Miniou Ph.D | InFlectis BioScience | Co-Founder, Chief Operating Officer & Board Member | 000 0000 |
| Taro Inaba | Remiges Ventures | Board Member | 000 0000 |
1 Former Board Member
InFlectis BioScience Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Crédit Mutuel Equity | Growth/Expansion | Minority | 000 0000 | 000000 0 | |
| Remiges Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Bpifrance | Sovereign Wealth Fund | Minority | 000 0000 | 000000 0 | |
| GO Capital (France) | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Participations Besançon | Venture Capital | Minority | 000 0000 | 000000 0 |
Ready to get started?
Request a free trial